Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial

The ATAC trial evaluates in a randomized, double-blind design, Arimidex™ (anastrozole) alone or in combination with tamoxifen, relative to tamoxifen alone as 5-year adjuvant treatment in postmenopausal women with early breast cancer. Patients included in the pharmacokinetic (PK) sub-protocol had bee...

Descripción completa

Detalles Bibliográficos
Autor principal: Trialists' Group, The ATAC
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364083/
https://www.ncbi.nlm.nih.gov/pubmed/11487258
http://dx.doi.org/10.1054/bjoc.2001.1925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364083/
https://www.ncbi.nlm.nih.gov/pubmed/11487258
http://dx.doi.org/10.1054/bjoc.2001.1925

Ejemplares similares